1Medical Department, CIBA-GEIGY AG, Basle, Switzerland.
This study examines Karl Popper's philosophy in clinical trials. It argues that blinding, randomization, and inclusion criteria are primarily for refuting hypotheses, not proving them, challenging common beliefs about induction in trial design.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: